The COVID-19 (SARS-CoV-2) uncertainty tripod in Brazil: Assessments on model-based predictions with large under-reporting

被引:13
|
作者
Bastos, Saulo B. [1 ,2 ]
Morato, Marcelo M. [3 ]
Cajueiro, Daniel O. [1 ,2 ,4 ]
Normey-Rico, Julio E. [3 ]
机构
[1] Univ Brasilia UnB, Dept Econ, FACE, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil
[2] Univ Brasilia UnB, Machine Learning Lab Finance & Org LAMFO, FACE, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil
[3] Univ Fed Santa Catarina UFSC, Dept Automacao & Sistemas, Renewable Energy Res Grp GPER, Florianopolis, SC, Brazil
[4] Nacl Inst Sci & Technol Complex Syst INCT SC, Brasilia, DF, Brazil
关键词
COVID-19; Under-reporting; SIR model; Uncertainty; Brazil;
D O I
10.1016/j.aej.2021.03.004
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The COVID-19 pandemic (SARS-CoV-2 virus) is the global crisis of our time. The absence of mass testing and the relevant presence of asymptomatic individuals causes the available data of the COVID-19 pandemic in Brazil to be largely under-reported regarding the number of infected individuals and deaths. We develop an adapted Susceptible-Infected-Recovered (SIR) model, which explicitly incorporates the under-reporting and the response of the population to public health policies (confinement measures, widespread use of masks, etc). Large amounts of uncertainty could provide misleading predictions of the COVID-19 spread. In this paper, we discuss the role of uncertainty in these model-based predictions, which is illustrated regarding three key aspects: (i) Assuming that the number of infected individuals is under-reported, we demonstrate anticipation regarding the infection peak. Furthermore, while a model with a single class of infected individuals yields forecasts with increased peaks, a model that considers both symptomatic and asymptomatic infected individuals suggests a decrease of the peak of symptomatic cases. (ii) Considering that the actual amount of deaths is larger than what is being registered, we demonstrate an increase of the mortality rates. (iii) When we consider generally under-reported data, we demonstrate how the transmission and recovery rate model parameters change qualitatively and quantitatively. We also investigate the "the uncertainty tripod": under-reporting level in terms of cases, deaths, and the true mortality rate of the disease. We demonstrate that if two of these factors are known, the remainder can be inferred, as long as proportions are kept constant. The proposed approach allows one to determine the margins of uncertainty by assessments on the observed and true mortality rates. (C) 2021 THE AUTHORS. Published by Elsevier BV on behalf of Faculty of Engineering, Alexandria University.
引用
收藏
页码:4363 / 4380
页数:18
相关论文
共 50 条
  • [21] Impact of SARS-CoV-2/COVID-19 on the placenta
    Menter, T.
    Tzankov, A.
    Bruder, E.
    PATHOLOGE, 2021, 42 (06): : 591 - 597
  • [22] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [23] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [24] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338
  • [25] SARS-CoV-2: The Monster Causes COVID-19
    Song, Chang
    Li, Zesong
    Li, Chen
    Huang, Meiying
    Liu, Jianhong
    Fang, Qiuping
    Cao, Zitong
    Zhang, Lin
    Gao, Pengbo
    Nie, Wendi
    Luo, Xueyao
    Kang, Jianhao
    Xie, Shimin
    Lyu, Jianxin
    Zhu, Xiao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [26] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [27] Pandemie durch SARS-CoV-2/Covid-19
    Matthias Schrappe
    Hedwig François-Kettner
    Franz Knieps
    Holger Pfaff
    K. Püschel
    Gerd Glaeske
    Medizinrecht, 2020, 38 (8) : 637 - 644
  • [28] SARS-CoV-2 seroprevalence in COVID-19 hotspots
    Eckerle, Isabella
    Meyer, Benjamin
    LANCET, 2020, 396 (10250): : 514 - 515
  • [29] Computation to Fight SARS-CoV-2 (COVID-19)
    Brogi, Simone
    Calderone, Vincenzo
    COMPUTATION, 2023, 11 (09)
  • [30] Decoding Covid-19 with the SARS-CoV-2 Genome
    Phoebe Ellis
    Ferenc Somogyvári
    Dezső P. Virok
    Michela Noseda
    Gary R. McLean
    Current Genetic Medicine Reports, 2021, 9 : 1 - 12